CD56-expressing T cells that have features of senescence are expanded in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 56, Issue 1, 2007, Pages 43-57

  Michel, Joshua J ^a   Turesson, Carl ^b   Lemster, Bonnie ^a   Atkins, Sarah R ^b   Iclozan, Cristina ^a   Bongartz, Tim ^b   Wasko, Mary Chester ^c   Matteson, Eric L ^b   Vallejo, Abbe N ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD56 ANTIGEN; CYTOKINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; METHOTREXATE; STEROID; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; ANTIGEN EXPRESSION; ARTHRITIS; ARTICLE; CELL AGING; CLONAL VARIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; INTERSTITIAL PNEUMONIA; LEUKOCYTE CULTURE; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENESCENCE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIGENS, CD56; ARTHRITIS, RHEUMATOID; BIOPSY; CELL CULTURE TECHNIQUES; FEMALE; FLOW CYTOMETRY; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES;

EID: 33846197453     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22310     Document Type: Article

References (54)

1. Cantagrel A, Lambert N, Alam A. T cell receptor gene in synovial tissues of rheumatoid arthritis. Int Rev Immunol 1998;17:323-37.
2. Weyand CM, Goronzy JJ. HLA polymorphisms and T cells in rheumatoid arthritis. Int Rev Immunol 1999;18:37-59.
3. Prakken BJ, Carson DA, Albani S. T cell repertoire formation and molecular mimicry in rheumatoid arthritis. Curr Dir Autoimmun 2001;3:51-63.
4. - T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996;97:2027-37.
5. - T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 2004;109:2744-8.
6. Riley JL, June CH. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood 2005;105:13-21.
7. Vallejo AN, Weyand CM, Goronzy JJ. Functional disruption of the CD28 gene transcriptional initiator in senescent T cells. J Biol Chem 2001;276:2565-70.
8. Martens PB, Goronzy JJ, Schaid D, Weyand CM. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum 1997;40:1106-14.
9. + T cell subsets: abnormal expression in rheumatoid arthritis. Clin Immunol 2001;99:253-65.
10. Bryl E, Vallejo AN, Matteson EL, Witkowski JM, Weyand CM, Goronzy JJ. Modulation of CD28 expression with anti-tumor necrosis factor α therapy in rheumatoid arthritis. Arthritis Rheum 2005;52:2996-3003.
11. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Occurrence of extra-articular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002;29:62-7.
12. Vallejo AN. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 2005;205:158-69.
13. Bryl E, Vallejo AN, Weyand CM, Goronzy JJ. Down-regulation of CD28 expression by TNF-α. J Immunol 2001;167:3231-8.
14. null T cells are associated with defects in apoptotic pathways. J Immunol 2000;165:6301-7.
15. + counterparts. J Immunol 1996;156:3587-90.
16. + T cells. J Immunol 2002;168:2225-32.
17. Vallejo AN, Weyand CM, Goronzy JJ. T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med 2004;10:119-24.
18. Skapenko A, Leipe J, Lipsky PE, Schulze-Koops H. The role of the T cell in autoimmune inflammation. Arthritis Res Ther 2005;7:S4-14.
19. Eck SC, Chang D, Wells AD, Turka LA. Differential down-regulation of CD28 by B7-1 and B7-2 engagement. Transplantation 1997;64:1497-9.
20. Vallejo AN, Brandes JC, Weyand CM, Goronzy JJ. Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. J Immunol 1999;162:6572-9.
21. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001;22:633-40.
22. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
23. + T cells is associated with the loss of gene-specific nuclear factor binding activity. J Biol Chem 1998;273:8119-29.
24. Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy." J Exp Med 1994;179:609-18.
25. Lewis DE, Merched-Sauvage M, Goronzy JJ, Weyand CM, Vallejo AN. Tumor necrosis factor-α and CD80 modulate CD28 expression through a similar mechanism of T-cell receptor-independent inhibition of transcription. J Biol Chem 2004;279:29130-8.
26. Abedin S, Michel JJ, Lemster B, Vallejo AN. Diversity of NKR expression in aging T cells and in T cells of the aged: the new frontier into the exploration of protective immunity in the elderly. Exp Gerontol 2005;40:537-48.
27. Hall FC, Thomson K, Procter J, McMichael AJ, Wordsworth BP. TCR β spectratyping in RA: evidence of clonal expansions in peripheral blood lymphocytes. Ann Rheum Dis 1998;57:319-22.
28. Turesson C, Matteson EL, Colby TV, Vuk-Pavlovic Z, Vassallo R, Weyand CM, et al. Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis. Arthritis Rheum 2005;52:73-9.
29. Vallejo AN, Mugge LO, Klimiuk PA, Weyand CM, Goronzy JJ. Central role of thrombospondin-1 in the activation and clonal expansion of inflammatory T cells. J Immunol 2000;164:2947-54.
30. Akolkar PN, Gulwani-Akolkar B, Pergolizzi R, Bigler RD, Silver J. Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes. J Immunol 1993;150:2761-73.
31. Barclay AN, Brown MH, Law SK, McKnight AJ, Tomlinson MG, van der Merwe PA. The leucocyte antigen facts book. 2nd ed. London: Academic Press; 1997.
32. Shay JW, Roninson IB. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 2004;23:2919-33.
33. Turesson C, Matteson EL. Management of extra-articular disease manifestations in rheumatoid arthritis. Curr Opin Rheumatol 2004;16:206-11.
34. Maury CP, Liljestrom M, Laiho K, Tiitinen S, Kaarela K, Hurme M. Tumor necrosis factor α, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis. Arthritis Rheum 2003;48:3068-76.
35. Turesson C, Englund P, Jacobsson LT, Sturfelt G, Truedsson L, Nennesmo I, et al. Increased endothelial expression of HLA-DQ and interleukin 1α in extra-articular rheumatoid arthritis: results from immunohistochemical studies of skeletal muscle. Rheumatology (Oxford) 2001;40:1346-54.
36. null T cells clonally expanded in rheumatoid arthritis. J Immunol 2000;165:1138-45.
37. Yen JH, Moore BE, Nakajima T, Scholl D, Schaid DJ, Weyand CM, et al. Major histocompatibility complex class I -recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 2001;193:1159-67.
38. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997;7:753-63.
39. Valenzuela HF, Effros RB. Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus. Clin Immunol 2002;105:117-25.
40. Wagner UG, Koetz K, Weyand CM, Goronzy JJ. Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci U S A 1998;95:14447-52.
41. Goronzy JJ, Weyand CM. Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity-catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther 2003;5:225-34.
42. Wasko MC. Comorbid conditions in patients with rheumatic diseases: an update. Curr Opin Rheumatol 2004;16:109-13.
43. Weyand CM, Goronzy JJ, Kurtin PJ. Lymphoma in rheumatoid arthritis: an immune system set up for failure [editorial]. Arthritis Rheum 2006;54:685-9.
44. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005;52:402-11.
45. Feldmann M, Maini RN. Anti-TNF α therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 2001;19:163-96.
46. Paillard F, Sterkers G, Vaquero C. Transcriptional and post-transcriptional regulation of TcR, CD4 and CDS gene expression during activation of normal human T lymphocytes. EMBO J 1990;9:1867-72.
47. Tarazona R, DelaRosa O, Alonso C, Ostos B, Espejo J, Pena J, et al. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev 2000;121:77-88.
48. Klareskog L, Stolt P, Lundberg. K, Kallberg H, Bengtsson C, Grunewald J, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006;54:38-46.
49. Davila E, Kang YM, Park YW, Sawai H, He X, Pryshchep S, et al. Cell-based immunotherapy with suppressor .CD8+ T cells in rheumatoid arthritis. J Immunol 2005;174:7292-301.
50. Vasallo R, Thomas CF. Advances in the treatment of rheumatic interstitial lung disease. Curr Opin Rheumatol 2004;16:186-91.
51. Benczik M, Gaffen SL. The interleukin (IL)-2 family cytokines: survival and proliferation signaling pathways in T lymphocytes. Immunol Invest 2004;33:109-42.
52. Maurer M, von Stebut E. Macrophage inflammatory protein-1. Int J Biochem Cell Biol 2004;36:1882-6.
53. Liu H, Pope RM. Phagocytes: mechanisms of inflammation and tissue destruction. Rheum Dis Clin North Am 2004;30:19-39.
54. Lanier LL, Chang C, Azuma M, Ruitenberg JJ, Hemperly JJ, Phillips JH. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56). J Immunol 1991;146:4421-6.